Literature DB >> 7979205

The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.

H F Vasen1, P Watson, J P Mecklin, J R Jass, J S Green, T Nomizu, H Müller, H T Lynch.   

Abstract

Family members from hereditary nonpolyposis colorectal cancer (HNPCC) families are at an increased risk of developing endometrial cancer. The present study was performed to investigate the epidemiology of endometrial cancer associated with HNPCC. Data on 125 cases of endometrial cancer from HNPCC families were collected from seven countries. The mean age at diagnosis was 48 years (range: 27-72 years). Fifty-seven percent of the cases were diagnosed under 50 years of age and 98 percent under 65 years. The mean ages at diagnosis of endometrial cancer were not significantly different between the countries. At the time of the investigation, 58 of the 125 cases had died (mean age at death: 59 years; range: 32-88 years). Fifteen of the 125 (12%) patients died from endometrial cancer. In 75 of the 113 (61%) endometrial cancer cases, a second primary cancer occurred. Most of these cancers (54 out of 75) were colorectal cancers. In 18 (15%) of the cases of endometrial cancers, more than two primary cancers occurred. In conclusion, endometrial cancer in HNPCC develops at a significant earlier age than in the general population. More than half of the cases had a second primary tumor. Endometrial cancer is an infrequent cause of death in the HNPCC families. A prospective study is warranted to assess the value of surveillance for endometrial cancer in these families.

Entities:  

Mesh:

Year:  1994        PMID: 7979205

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

Review 1.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

2.  Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.

Authors:  Nina Pauly; Thaïs Baert; Rita Schmutzler; Andreas du Bois; Stephanie Schneider; Kerstin Rhiem; Birgid Schömig-Markiefka; Janna Siemanowski; Sebastian Heikaus; Alexander Traut; Florian Heitz; Sonia Prader; Sarah Ehmann; Philipp Harter; Beyhan Ataseven
Journal:  Arch Gynecol Obstet       Date:  2021-03-12       Impact factor: 2.344

Review 3.  Surveillance in Lynch syndrome.

Authors:  Jukka-Pekka Mecklin; Heikki J Järvinen
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  Gynecologic Cancers in Lynch Syndrome/HNPCC.

Authors:  Karen H Lu; Russell R Broaddus
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer.

Authors:  Amanda S Bruegl; Bojana Djordjevic; Diana L Urbauer; Shannon N Westin; Pamela T Soliman; Karen H Lu; Rajyalakshmi Luthra; Russell R Broaddus
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.

Authors:  Larissa A Meyer; Russell R Broaddus; Karen H Lu
Journal:  Cancer Control       Date:  2009-01       Impact factor: 3.302

Review 7.  Prostate cancer in young men: an important clinical entity.

Authors:  Claudia A Salinas; Alex Tsodikov; Miriam Ishak-Howard; Kathleen A Cooney
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

Review 8.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 9.  Current and emerging trends in Lynch syndrome identification in women with endometrial cancer.

Authors:  Kimberly E Resnick; Heather Hampel; Richard Fishel; David E Cohn
Journal:  Gynecol Oncol       Date:  2009-04-17       Impact factor: 5.482

10.  Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.

Authors:  Lotte H M Gerritzen; Nicoline Hoogerbrugge; Angèle L M Oei; Fokko M Nagengast; Maaike A P C van Ham; Leon F A G Massuger; Joanne A de Hullu
Journal:  Fam Cancer       Date:  2009-06-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.